Department of Psychiatry,
Yale Child Study Center,
Interdepartmental Neuroscience Program
Christopher Pittenger has not added Biography.
If you are Christopher Pittenger and would like to personalize this page please email our Author Liaison for assistance.
Reversible inhibition of CREB/ATF transcription factors in region CA1 of the dorsal hippocampus disrupts hippocampus-dependent spatial memory.
Neuron Apr, 2002 | Pubmed ID: 11988175
CREB, memory enhancement and the treatment of memory disorders: promises, pitfalls and prospects.
Expert opinion on therapeutic targets Feb, 2003 | Pubmed ID: 12556206
In search of general mechanisms for long-lasting plasticity: Aplysia and the hippocampus.
Philosophical transactions of the Royal Society of London. Series B, Biological sciences Apr, 2003 | Pubmed ID: 12740123
[Past and future studies of memory].
KOS Apr, 2003 | Pubmed ID: 12760381
A form of long-lasting, learning-related synaptic plasticity in the hippocampus induced by heterosynaptic low-frequency pairing.
Proceedings of the National Academy of Sciences of the United States of America Jan, 2004 | Pubmed ID: 14711997
Toward a neurobiology of psychotherapy: basic science and clinical applications.
The Journal of neuropsychiatry and clinical neurosciences , 2005 | Pubmed ID: 15939967
Riluzole augmentation in treatment-resistant obsessive-compulsive disorder: an open-label trial.
Biological psychiatry Sep, 2005 | Pubmed ID: 15993857
N-acetylcysteine augmentation in serotonin reuptake inhibitor refractory obsessive-compulsive disorder.
Psychopharmacology Jan, 2006 | Pubmed ID: 16374600
Initial evidence of the beneficial effects of glutamate-modulating agents in the treatment of self-injurious behavior associated with borderline personality disorder.
The Journal of clinical psychiatry Nov, 2005 | Pubmed ID: 16420092
Glutamate-modulating drugs as novel pharmacotherapeutic agents in the treatment of obsessive-compulsive disorder.
NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics Jan, 2006 | Pubmed ID: 16490414
Impaired bidirectional synaptic plasticity and procedural memory formation in striatum-specific cAMP response element-binding protein-deficient mice.
The Journal of neuroscience : the official journal of the Society for Neuroscience Mar, 2006 | Pubmed ID: 16525060
Visual hallucinations from the addition of riluzole to memantine and bupropion.
Journal of clinical psychopharmacology Apr, 2006 | Pubmed ID: 16633160
Beneficial effects of the glutamate-modulating agent riluzole on disordered eating and pathological skin-picking behaviors.
Journal of clinical psychopharmacology Dec, 2006 | Pubmed ID: 17110840
Beneficial effects of the antiglutamatergic agent riluzole in a patient diagnosed with trichotillomania.
The Journal of clinical psychiatry Jan, 2007 | Pubmed ID: 17284151
Gabapentin abuse, and delirium tremens upon gabapentin withdrawal.
The Journal of clinical psychiatry Mar, 2007 | Pubmed ID: 17388722
The NMDA receptor as a therapeutic target in major depressive disorder.
CNS & neurological disorders drug targets Apr, 2007 | Pubmed ID: 17430148
Systematic review: pharmacological and behavioral treatment for trichotillomania.
Biological psychiatry Oct, 2007 | Pubmed ID: 17727824
Stress, depression, and neuroplasticity: a convergence of mechanisms.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology Jan, 2008 | Pubmed ID: 17851537
Association of the serotonin transporter polymorphism and obsessive-compulsive disorder: systematic review.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics Sep, 2008 | Pubmed ID: 18186076
Riluzole augmentation in treatment-refractory obsessive-compulsive disorder: a series of 13 cases, with long-term follow-up.
Journal of clinical psychopharmacology Jun, 2008 | Pubmed ID: 18480706
Blocking TGF-beta-Smad2/3 innate immune signaling mitigates Alzheimer-like pathology.
Nature medicine Jun, 2008 | Pubmed ID: 18516051
Riluzole in the treatment of mood and anxiety disorders.
CNS drugs , 2008 | Pubmed ID: 18698875
Meta-analysis of the symptom structure of obsessive-compulsive disorder.
The American journal of psychiatry Dec, 2008 | Pubmed ID: 18923068
A double dissociation revealing bidirectional competition between striatum and hippocampus during learning.
Proceedings of the National Academy of Sciences of the United States of America Nov, 2008 | Pubmed ID: 18955704
Dimensional predictors of response to SRI pharmacotherapy in obsessive-compulsive disorder.
Journal of affective disorders Feb, 2010 | Pubmed ID: 19577308
Inhibition of CREB activity in the dorsal portion of the striatum potentiates behavioral responses to drugs of abuse.
Frontiers in behavioral neuroscience , 2009 | Pubmed ID: 19826621
Cued and spatial learning in the water maze: equivalent learning in male and female mice.
Neuroscience letters Oct, 2010 | Pubmed ID: 20691760
Genetic reduction of striatal-enriched tyrosine phosphatase (STEP) reverses cognitive and cellular deficits in an Alzheimer's disease mouse model.
Proceedings of the National Academy of Sciences of the United States of America Nov, 2010 | Pubmed ID: 20956308
Dissociable regulation of instrumental action within mouse prefrontal cortex.
The European journal of neuroscience Nov, 2010 | Pubmed ID: 21044173
Clinical treatment of obsessive compulsive disorder.
Psychiatry (Edgmont (Pa. : Township)) Nov, 2005 | Pubmed ID: 21120095
Recent advances in Tourette syndrome.
Current opinion in neurology Apr, 2011 | Pubmed ID: 21386676
Epigenetic modification of the BDNF locus by early-life enrichment: towards a molecular correlate of resilience?
Neuroscience letters May, 2011 | Pubmed ID: 21435373
High levels of histidine decarboxylase in the striatum of mice and rats.
Neuroscience letters May, 2011 | Pubmed ID: 21440039
Association of polymorphisms in HCN4 with mood disorders and obsessive compulsive disorder.
Neuroscience letters Jun, 2011 | Pubmed ID: 21529705
Dimensional correlates of poor insight in obsessive-compulsive disorder.
Progress in neuro-psychopharmacology & biological psychiatry Aug, 2011 | Pubmed ID: 21640153
Glutamate abnormalities in obsessive compulsive disorder: neurobiology, pathophysiology, and treatment.
Pharmacology & therapeutics Dec, 2011 | Pubmed ID: 21963369
Pathophysiological modeling of obsessive-compulsive disorder: challenges, and progress.
Biological psychiatry Dec, 2011 | Pubmed ID: 22045035
SOBRE A JoVE
Copyright © 2024 MyJoVE Corporation. Todos os direitos reservados